{"schema_version":"1","generated_at":"2026-10-28T03:17:08.187Z","data_as_of":null,"url":"https://www.findmykol.com/kol/iris-sheng","json_url":"https://www.findmykol.com/kol/iris-sheng/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"iris-sheng","name":"Iris Sheng","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"Cambridge","state":"MA","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1578942058","orcid":"0009-0007-4999-6733","openalex":"A5087463997"},"summary":"Iris Sheng is an Oncology physician. OpenAlex indexes 80 publications with 345 citations (h-index 10).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":80,"cited_by_count":345,"h_index":10,"latest_activity_year":2026,"source":"works"},"payments":{"company_count":12,"program_years":{"first":2021,"last":null},"rows_total":14,"shown":3,"withheld":11,"rows":[{"payer":"E.R. Squibb & Sons, L.L.C.","program_year":2025,"amount_usd":60.53,"payment_count":3,"source_url":"https://openpaymentsdata.cms.gov/search?query=1578942058"},{"payer":"SUN PHARMACEUTICAL INDUSTRIES INC.","program_year":2025,"amount_usd":20.44,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1578942058"},{"payer":"Rigel Pharmaceuticals, Inc.","program_year":2025,"amount_usd":14.84,"payment_count":1,"source_url":"https://openpaymentsdata.cms.gov/search?query=1578942058"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1578942058","source":"payments"},"publications":{"total":50,"shown":5,"withheld":45,"matched_by":"OpenAlex author record","recent":[{"title":"Integrating circulating tumor DNA (ctDNA) and <i>TP53</i> alteration variant allele frequency (VAF) to predict outcomes in advanced urothelial carcinoma (aUC) treated with enfortumab vedotin (EV).","year":2026,"journal":"Journal of Clinical Oncology","source_url":"https://doi.org/10.1200/jco.2026.44.7_suppl.815","status":"verified"},{"title":"Corneal transplant rejection after treatment with pembrolizumab: report of two cases","year":2026,"journal":"Journal of Cataract & Refractive Surgery Online Case Reports","source_url":"https://doi.org/10.1097/j.jcro.0000000000000244","status":"verified"},{"title":"Immune checkpoint inhibitors in urothelial carcinoma: a practical framework for patient selection, toxicity management, response assessment, and treatment sequencing","year":2026,"journal":"Expert Review of Anticancer Therapy","source_url":"https://doi.org/10.1080/14737140.2026.2628071","status":"verified"},{"title":"Abstract PS2-06-01: Real World Outcomes of the Keynote 522 Regimen for Triple-Negative Breast Cancer","year":2026,"journal":"Clinical Cancer Research","source_url":"https://doi.org/10.1158/1557-3265.sabcs25-ps2-06-01","status":"verified"},{"title":"Advances in Oncolytic Viral Therapy in Melanoma: A Comprehensive Review","year":2025,"journal":"Vaccines","source_url":"https://doi.org/10.3390/vaccines13070727","status":"verified"}],"source":"works"},"contact":{"address_1":"100 MOUNT AUBURN ST","city":"Cambridge","state":"MA","zip":"021385051","phone":"617-497-9646","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1578942058","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Larry Norton","slug":"larry-norton","institution":"Memorial Sloan Kettering Cancer Center","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/larry-norton","json_url":"https://www.findmykol.com/kol/larry-norton/profile.json"}],"coverage":{"note":"A basic record from the physician directory. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":11,"publications":45}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2021-10-08","provider_certified":"2021-10-08","collected_at":"2026-10-27T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}